Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5997)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 15, 2021 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma S, Liu H, Ma FH, Li Y, Jin P, Hu HT, Kang WZ, Li WK, Xiong JP, Tian YT. Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer. World J Gastrointest Oncol 2021; 13(3): 161-173 [PMID: 33738044 DOI: 10.4251/wjgo.v13.i3.161] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v13/i3/161.htm |
| Number | Citing Articles |
| 1 |
Hongfa Wei, Xiao-Yong Zhan, Xianying Liao, Wenchao Li, Hui Chen, Cuncan Deng, Xinghan Jin, Zhangsen Huang, Mo Yang, Changhua Zhang, Yulong He. Gastric cancer clinical characteristics and their altered trends in South China: An epidemiological study with 2,800 cases spanning 26 years. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.976854
|
| 2 |
H. Wen, G. Deng, X. Shi, Z. Liu, A. Lin, Q. Cheng, J. Zhang, P. Luo. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies. ESMO Open 2024; 9(3): 102241 doi: 10.1016/j.esmoop.2024.102241
|
| 3 |
Wei Peng, Jing Dai, Chao-chan Liu, Dian Liu, Hua Xiao. Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.899677
|